Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.64 |
| ▸ | MEN1 | O00255 | 9/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.64 |
| ▸ | RAB9A | P51151 | 8/20 | 0.64 |
| ▸ | NPC1 | O15118 | 8/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.64 |
| ▸ | HPGD | P15428 | 6/20 | 0.64 |
| ▸ | PKM | P14618 | 3/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 7/20 | 0.62 |
| ▸ | GAA | P10253 | 4/20 | 0.62 |
| ▸ | GLA | P06280 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 4/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | ATP4A | P20648 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1298605 | 1.00 | MAPT (0.66) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL31252955 | 1.00 | MAPT (0.66) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL15624226 | 0.87 | NPC1 (0.73) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL30422072 | 0.85 | MAPT (0.61) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL31252953 | 0.85 | MAPT (0.71) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL2497906 | 0.85 | MAPT (0.71) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL2497904 | 0.85 | MAPT (0.71) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL31305038 | 0.84 | NPC1 (0.89) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL6482368 | 0.82 | MAPT (0.46) | MAPTTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL5572508 | 0.80 | NPC1 (0.76) | MAPTTP53ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020162630-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | ダイキン工業株式会社 | 2020-08-13 | — | — | WO | disclosed |
| EP-2567954-B1 | METHOD FOR INHIBITING TAU PROTEIN AGGREGATION AND TREATMENT OF ALZHEIMER'S DISEASE WITH A COMPOUND DERIVED FROM QUINOLINE | UNIV CHILE (CL) | 2014-06-18 | — | — | EP | disclosed |
| US-8575288-B2 | Photocurable resin composition for forming overcoats RGB pixels black matrixes or spacers in color filter production, and color filters | DAI NIPPON PRINTING CO., LTD. (JP) | 2013-11-05 | — | — | US | disclosed |
| EP-2567954-A1 | METHOD FOR INHIBITING TAU PROTEIN AGGREGATION AND TREATMENT OF ALZHEIMER'S DISEASE WITH A COMPOUND DERIVED FROM QUINOLINE | Universidad De Chile (CL) | 2013-03-13 | — | — | EP | disclosed |
| US-8198300-B2 | Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound | UNIVERSIDAD DE CHILE (CL) | 2012-06-12 | — | — | US | disclosed |
| US-20110269793-A1 | METHOD FOR PREVENTING TAU PROTEIN AGGREGATION AND TREATING ALZHEIMER'S DISEASE WITH A QUINOLINE DERIVATIVE COMPOUND | UNIVERSIDAD DE CHILE (CL) | 2011-11-03 | — | — | US | disclosed |
| US-8029877-B2 | Curable resin composition, curable resin composition for forming photosensitive pattern, color filter, liquid crystal panel substrate and liquid crystal panel | DAI NIPPON PRINTING CO., LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| US-20100238388-A1 | CURABLE RESIN COMPOSITION, CURABLE RESIN COMPOSITION FOR FORMING PHOTOSENSITIVE PATTERN, COLOR FILTER, LIQUID CRYSTAL PANEL SUBSTRATE AND LIQUID CRYSTAL PANEL | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
| US-7537810-B2 | Curable resin composition, photosensitive pattern-forming curable resin composition, color filter, substrate for liquid crystalline panel, and liquid crystalline panel | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-05-26 | — | — | US | disclosed |
| US-7399574-B2 | Curable resin for photo-patterning, process for producing the same, curable resin composition, color filter, liquid crystal panel substrate, and liquid crystal panel | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20060229376-A1 | Curable resin composition, photosensitive pattern-forming curable resin composition,color filter, substrate for liquid crystalline panel, and liquid crystalline panel | DAI NIPPON PRINTING CO., LTD. (JP) | 2006-10-12 | — | — | US | disclosed |
| US-20030118922-A1 | Curable resin for photo-patterning, process for producing the same, curable resin composition, color filter, liquid crystal panel substrate, and liquid crystal panel | DAI NIPPON PRINTING CO., LTD. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269793-A1 | METHOD FOR PREVENTING TAU PROTEIN AGGREGATION AND TREATING ALZHEIMER'S DISEASE WITH A QUINOLINE DERIVATIVE COMPOUND | MAPT, PSEN2, APP | MAPT 1/4885TP53 1763/4885ALDH1A1 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.